| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/10/2013 | US8530405 Method of preparing water-soluble and biodegradable antimicrobial agent |
| 09/10/2013 | US8530234 Hepatitis C virus vaccine |
| 09/10/2013 | US8530223 Method to grow Lawsonia intracellularis bacteria in persistently infected McCoy cells |
| 09/10/2013 | US8529935 Antibacterial hydrogel and use thereof in orthopedics |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | CA2673254C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 09/10/2013 | CA2608058C Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 09/10/2013 | CA2589529C 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 09/10/2013 | CA2579501C Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 09/10/2013 | CA2577588C Hiv inhibiting bicyclic pyrimidine derivatives |
| 09/10/2013 | CA2574301C (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 09/10/2013 | CA2446848C Derivatives of magainin |
| 09/10/2013 | CA2431964C Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 09/10/2013 | CA2392527C Hbv/hcv virus-like particle |
| 09/06/2013 | WO2013130981A1 Human antibodies to clostridium difficile toxins |
| 09/06/2013 | WO2013130766A1 Spray dried formulations |
| 09/06/2013 | WO2013130565A1 Neutralizing antibody for epstein barr virus associated disease |
| 09/06/2013 | WO2013129953A1 Vaccine against strangles of the equidae |
| 09/06/2013 | WO2013129944A1 Controlled release compositions and their methods of use |
| 09/06/2013 | WO2013129929A1 Methods for activating retrovirus in latent infected cells, and compounds for use therein |
| 09/06/2013 | WO2013128031A1 Pseudomonas aeruginosa pcrv binding single variable domain antibodies |
| 09/06/2013 | WO2013128029A1 Pharmaceutically active pyrazolo-triazine derivatives |
| 09/06/2013 | WO2013128028A1 Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors |
| 09/06/2013 | WO2013128022A1 Method for preventing or treating a hepatitis c virus infection or a hepatitis b virus infection by administration of suicide gene-modified lymphocytes |
| 09/06/2013 | WO2013127976A1 Method for the preparation of dendritic cell vaccines |
| 09/06/2013 | WO2013126962A1 Therapeutic and diagnostic agents |
| 09/05/2013 | US20130230609 Antimicrobial/preservative compositions comprising botanicals |
| 09/05/2013 | US20130230600 Therapeutic agent |
| 09/05/2013 | US20130230526 Klebsiella antigens |
| 09/05/2013 | US20130230522 Complement Pathway Inhibitors Binding To C5 and C5A Without Preventing The Formation of C5B |
| 09/04/2013 | EP2634190A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors |
| 09/04/2013 | EP2634189A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| 09/04/2013 | EP2633867A1 Vaccine for protection against Lawsonia intracellularis, Mycoplasma hyopneumoniae and Porcine circo virus |
| 09/04/2013 | EP2633866A2 Combination therapy |
| 09/04/2013 | EP2633865A1 Use of interleukin-22 in treating viral hepatitis |
| 09/04/2013 | EP2633864A1 Clip inhibitors and methods of modulating immune function |
| 09/04/2013 | EP2633862A1 Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof |
| 09/04/2013 | EP2633859A1 Use of biological surfactant as anti-inflammatory agent and tissue preservative solution |
| 09/04/2013 | EP2633051A1 Hbv treatment |
| 09/04/2013 | EP2632953A1 Antibodies for the treatment of hiv |
| 09/04/2013 | EP2632949A1 Clostridium difficile-specific antibodies and uses thereof |
| 09/04/2013 | EP2632942A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same |
| 09/04/2013 | EP2632941A2 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same |
| 09/04/2013 | EP2632933A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases |
| 09/04/2013 | EP2632921A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl]methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders |
| 09/04/2013 | EP2632908A1 Sulfonamides as hiv protease inhibitors |
| 09/04/2013 | EP2632895A1 Hiv protease inhibitors |
| 09/04/2013 | EP2632552A1 Inhibition of microbial growth by aconitase inhibition |
| 09/04/2013 | EP2632487A2 Viral vaccine and process for preparing the same |
| 09/04/2013 | EP2632484A2 Filovirus fusion proteins and their uses |
| 09/04/2013 | EP2632460A2 Compositions and methods for treating tuberculosis |
| 09/04/2013 | EP2632433A2 Liquid formulations of long acting interferon alpha conjugate |
| 09/04/2013 | EP2632261A1 Inhibitors of hepatitis c virus |
| 09/04/2013 | CN1578670B Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 09/04/2013 | CN103282385A Fusion proteins for HIV therapy |
| 09/04/2013 | CN103282370A Antibacterial amiinoglycoside analogs |
| 09/04/2013 | CN103282369A Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof |
| 09/04/2013 | CN103282367A Novel antifungal 5,6-ihydro-4h-pyrrolo[1,2-a][1,4]- benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives |
| 09/04/2013 | CN103282366A Compounds for treating respiratory syncytial virus infections |
| 09/04/2013 | CN103282038A Phosphomycin pharmaceutical composition |
| 09/04/2013 | CN103275971A RNA interference targets for hepatitis b virus (HBV) infection treatment |
| 09/04/2013 | CN103275939A Recombinant virus of chimeric IBV H120 S1 gene ectodomain suitable for cell culture and construction method and application thereof |
| 09/04/2013 | CN103275938A Preparation method of PCV2 (Porcine Circovirus2)-D |
| 09/04/2013 | CN103275937A Recombinant virus expressing PCV2 codon optimized ORF1 and ORF2 tandem gene |
| 09/04/2013 | CN103275933A Human liver cancer cell line HLCZ01 and application thereof |
| 09/04/2013 | CN103275912A Enterohemorrhagic Escherichia coli (EHEC) O157:H7 multivalent fliC-hcpA-tir-eae recombinant bacteria and vaccines |
| 09/04/2013 | CN103275890A Vibrio anguillarum (listonella anguillarum) virulent strain and application thereof |
| 09/04/2013 | CN103275228A K99-987P-F41 recombinant protein and application thereof |
| 09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
| 09/04/2013 | CN103275214A Gene engineering preparation and identification method for shrimp serine protease inhibitor |
| 09/04/2013 | CN103275190A Small molecular polypeptide ZY13 and application thereof |
| 09/04/2013 | CN103275159A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/04/2013 | CN103275157A Rupestonic acid amide derivative containing heterocyclic ring and sugar, preparation method and purposes thereof |
| 09/04/2013 | CN103275156A Rupestonic acid ester derivatives containing heterocycle and glycosyl and preparation methods and applications thereof |
| 09/04/2013 | CN103275154A Preparation method of crystalline particles of acetyl isovaleryl tylosin salt |
| 09/04/2013 | CN103275148A Preparation method of icariin |
| 09/04/2013 | CN103275105A Azasugar thiazine alkane ketone derivative, synthetic method and application thereof in medicinal preparation |
| 09/04/2013 | CN103275081A Carbapenems antibiotics |
| 09/04/2013 | CN103275066A 3, 5-disubstituted 4-aminotriazole compound, as well as preparation method and application thereof |
| 09/04/2013 | CN103275041A Five-membered heterocyclic dicarbonyl derivative and applications thereof for resisting multidrug-resistant bacteria |
| 09/04/2013 | CN103275033A Modulators of pharmacokinetic properties of therapeutics |
| 09/04/2013 | CN103275024A Azole antifungal compound and its preparation method and application |
| 09/04/2013 | CN103274970A Antiviral compounds and methods |
| 09/04/2013 | CN103274969A Derivatives and using of anti-flu and anti-avian-flu medicine |
| 09/04/2013 | CN103272245A Curcumin and mixed-cyclodextrin inclusion compound and preparation method thereof |
| 09/04/2013 | CN103272240A Composite heat protectant for specific transfer factor of nephropathogenic infectious bronchitis, and application thereof |
| 09/04/2013 | CN103272230A Triple vaccine special for Muscovy duck |
| 09/04/2013 | CN103272229A Oral agent for blocking prawns from infecting white spot syndrome viruses, and preparation method and application thereof |
| 09/04/2013 | CN103272228A Biological control method of crucian hemorrhagic disease and application thereof |
| 09/04/2013 | CN103272226A Pharmaceutical composition for controlling poultry mould infection |
| 09/04/2013 | CN103272210A Pharmaceutical composition for treating osteoarthrosis and brucellosis and preparation method thereof |
| 09/04/2013 | CN103272206A Traditional Chinese medicine composition for treating mycotic dermatitis of pet and preparation method of traditional Chinese medicine composition |
| 09/04/2013 | CN103272200A Traditional Chinese medicine oral liquid for treating duck viral hepatitis and preparation method thereof |
| 09/04/2013 | CN103272153A Antibacterial gel and preparation method thereof |
| 09/04/2013 | CN103272138A Traditional Chinese medicine for treating rubella |
| 09/04/2013 | CN103272134A Medicine for killing acid-fast staining positive (red) bacillus |
| 09/04/2013 | CN103272121A Tetanus treatment traditional Chinese medicine preparation |
| 09/04/2013 | CN103272117A Traditional Chinese medicine granules for treating infectious bronchitis of chick and preparation method thereof |
| 09/04/2013 | CN103272110A Oral Chinese medicine preparation for treating piglet bacterial dysentery and preparation method thereof |